Last reviewed · How we verify

high bile acid binding blenderized diet

Boston Children's Hospital · FDA-approved active Small molecule

A specialized blenderized diet formulation that binds bile acids in the gastrointestinal tract to reduce their reabsorption and lower circulating bile acid levels.

A specialized blenderized diet formulation that binds bile acids in the gastrointestinal tract to reduce their reabsorption and lower circulating bile acid levels. Used for Progressive familial intrahepatic cholestasis (PFIC), Bile acid malabsorption disorders.

At a glance

Generic namehigh bile acid binding blenderized diet
SponsorBoston Children's Hospital
Drug classDietary intervention / Bile acid sequestrant
ModalitySmall molecule
Therapeutic areaGastroenterology / Hepatology
PhaseFDA-approved

Mechanism of action

This dietary intervention increases bile acid sequestration in the intestinal lumen, preventing enterohepatic circulation and promoting fecal excretion of bile acids. By reducing systemic bile acid levels, the diet aims to ameliorate symptoms and complications associated with bile acid malabsorption or elevated bile acid metabolism. This is a non-pharmacological approach used primarily in pediatric patients with specific metabolic or hepatic conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: